A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

Benlysta is the first and only approved autoinjector biologic for both systemic lupus erythematosus and lupus nephritis ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...

The supermarket chain Harris Teeter issued a voluntary recall for a wide variety of ZENSHI sushi products in seven states.

The FDA said risks linked to CAR-T cell therapies can be effectively communicated through existing labeling, including boxed ...

By Denise Mann HealthDay ReporterMONDAY, June 30, 2025 (HealthDay News) — Nestle has joined a growing list of major food ...

Explore the latest on VYVGART HYTRULO's FDA safety signal and transition challenges. Learn why argenx's balanced risks keep ...

The CDC and FDA recommend using a combination of shade, protective clothing, sunglasses, and broad-spectrum sunscreen with ...

Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS.

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...